NCT02275533 2026-03-19
Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Astellas Pharma Inc
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Mayo Clinic